Viewing Study NCT06523868



Ignite Creation Date: 2024-10-25 @ 8:06 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06523868
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-23

Brief Title: Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population The Sentinel Study
Sponsor: None
Organization: None

Study Overview

Official Title: Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population The Sentinel Study
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this research study is to evaluate the possible benefits of an investigational but commercially available Galleri multi-cancer early detection MCED blood test which is designed to detect many types of cancer early in veterans who have served in the military in active duty

The name of the screening blood test being studied is

-GRAIL Galleri MCED test
Detailed Description: This research study aims to assess the performance of the Galleri multi-cancer early detection MCED screening test in a military population and to compare the number and types of cancers diagnosed using MCED testing versus standard of care This research study will give doctors and participants results of Galleri blood tests which is designed to detect many types of cancer

The research study procedures including screening for eligibility blood draws questionnaires and clinic visits

Participation in this research study is expected to last for up to 1 year

It is expected that about 1500 people will take part in this research study

The Department of Defense DoD is funding this study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None